Literature DB >> 1318123

The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system.

K Felgenhauer1, H Reiber.   

Abstract

The antibody specificity index (ASI) indicates the cerebrospinal fluid (CSF)/serum difference of antibody amounts per weight unit IgG (normal less than 1.5). It has proven to be the most sensitive inflammation parameter in CSF analysis so far, more sensitive than the Western blot, the "oligoclonal" response, and the empirical differentiation of CSF immunoglobulins. By this diagnostic criterion, several benign viral meningitis cases were found to be caused by the varicella/zoster virus. The diagnostic relevance of local zoster antibody synthesis was greatest in ganglionitis cases, e.g., in zoster oticus sine herpete (facial paresis) and acute radicular syndromes of the elderly. The diagnostic significance of the local immune response against measles, rubella, and zoster antigens (MRZ response) was ascertained further. Together with oligoclonal gamma-globulin fractionation, there is now only 1 out of 100 multiple sclerosis (MS) patients left who has been found to have a normal CSF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318123     DOI: 10.1007/bf00422934

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  30 in total

1.  Demonstration of herpes simplex virus DNA in CSF cells by in situ hybridization for early diagnosis of herpes encephalitis.

Authors:  S Bamborschke; A Porr; M Huber; W D Heiss
Journal:  J Neurol       Date:  1990-04       Impact factor: 4.849

2.  Detection of antibodies to herpes simplex virus in the cerebrospinal fluid of patients with herpes simplex encephalitis.

Authors:  J Kahlon; S Chatterjee; F D Lakeman; F Lee; A J Nahmias; R J Whitley
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

3.  Immunoglobulin G subclass antibodies to measles virus in patients with subacute sclerosing panencephalitis or multiple sclerosis.

Authors:  P D Mehta; B A Patrick; W Sobczyk; J Kulczycki; J Woyciechowska-Camenga; D Camenga; H Thormar
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

4.  Measles virus polypeptide-specific antibody profile in multiple sclerosis.

Authors:  S Dhib-Jalbut; K Lewis; E Bradburn; D E McFarlin; H F McFarland
Journal:  Neurology       Date:  1990-03       Impact factor: 9.910

5.  Changes in cerebrospinal fluid cells, IgG and IgA during herpes simplex virus encephalitis in rabbits.

Authors:  O L Laskin; D E Griffin
Journal:  J Neuroimmunol       Date:  1987-04       Impact factor: 3.478

6.  Detection of herpes simplex virus type 1-IgM immune complexes in the brain of a patient with prolonged herpes encephalitis.

Authors:  K Hayashi; K Yanagi; S Takagi
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

7.  A sensitive ELISA system for the rapid detection of virus specific IgM antibodies in the cerebrospinal fluid.

Authors:  M K Sharief; E J Thompson
Journal:  J Immunol Methods       Date:  1990-06-12       Impact factor: 2.303

8.  Antiviral IgM and IgG subclasses in varicella zoster associated neurological syndromes.

Authors:  T Mathiesen; A Linde; E Olding-Stenkvist; B Wahren
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

9.  Diagnosis of herpes simplex virus encephalitis by detection of virus-specific immunoglobulins A and G in serum and cerebrospinal fluid by using an antibody-capture enzyme-linked immunosorbent assay.

Authors:  A M van Loon; J T van der Logt; F W Heessen; B Postma; M F Peeters
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

10.  Immunological diagnosis in viral infections of the central nervous system: course of antibody titres against homo- and heterologous viruses.

Authors:  R H Dennin; E Herb
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

View more
  32 in total

Review 1.  Body fluid biomarkers for multiple sclerosis--the long road to clinical application.

Authors:  Charlotte E Teunissen; Arjan Malekzadeh; Cyra Leurs; Claire Bridel; Joep Killestein
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

Review 2.  The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.

Authors:  Martin Stangel; Sten Fredrikson; Edgar Meinl; Axel Petzold; Olaf Stüve; Hayrettin Tumani
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

3.  Breakdown of multiple sclerosis genetics to identify an integrated disease network and potential variant mechanisms.

Authors:  C Joy Shepard; Sara G Cline; David Hinds; Seyedehameneh Jahanbakhsh; Jeremy W Prokop
Journal:  Physiol Genomics       Date:  2019-09-04       Impact factor: 3.107

4.  Expanding the spectrum of neurological disease associated with Epstein-Barr virus activity.

Authors:  M Kleines; J Schiefer; A Stienen; M Blaum; K Ritter; M Häusler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-15       Impact factor: 3.267

Review 5.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Authors:  S Jarius; P Eichhorn; D Franciotta; H F Petereit; G Akman-Demir; M Wick; B Wildemann
Journal:  J Neurol       Date:  2016-12-22       Impact factor: 4.849

6.  The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.

Authors:  Tilman Hottenrott; Elisabeth Schorb; Kristina Fritsch; Rick Dersch; Benjamin Berger; Daniela Huzly; Sebastian Rauer; Ludger Tebartz van Elst; Dominique Endres; Oliver Stich
Journal:  J Neurol       Date:  2018-03-06       Impact factor: 4.849

Review 7.  The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C J Sindic; A M van Loon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

Review 8.  Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature.

Authors:  Klemens Ruprecht; Brigitte Wildemann; Sven Jarius
Journal:  J Neurol       Date:  2017-11-02       Impact factor: 4.849

Review 9.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

10.  IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome.

Authors:  Johannes Brettschneider; Hayrettin Tumani; Ulrike Kiechle; Rainer Muche; Gayle Richards; Vera Lehmensiek; Albert C Ludolph; Markus Otto
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.